The Biden administration announced on Monday its plan to make rapid, at-home COVID-19 tests cheaper and more available through an accelerated Food and Drug Administration (FDA) authorization process.
The National Institutes of Health (NIH) plans to commit $70 million from the American Rescue Plan to boost the number of over-the-counter at-home COVID-19 tests on the market.
Under this strategy, the Department of Health and Human Services (HHS) plans to prioritize FDA authorization applications for COVID-19 tests from companies that “have the potential for manufacturing at significant scale.” ...
Recent Comments